<DOC>
	<DOCNO>NCT00945243</DOCNO>
	<brief_summary>This multi-center , prospective , outcomes study . In study , Zero-P PEEK implant use patient undergoing ACDF treatment SCDD single level C3 C7 . The cohort follow time twenty-four ( 24 ) month surgery . Up fifteen ( 15 ) site participate study . This control study .</brief_summary>
	<brief_title>Clinical Outcomes Study Evaluating Zero-P PEEK</brief_title>
	<detailed_description>This post-market study</detailed_description>
	<criteria>1 . Symptomatic cervical disc disease ( SCDD ) one vertebral level C3C7 requiring : 1 . Neck arm ( radicular ) pain and/or 2 . Functional/neurological deficit confirm imaging ( CT , MRI , XRay ) least one following : i. herniated nucleus pulposus ii . spondylosis ( define presence osteophyte ) iii . loss disc height 2 . NDI score great equal 15/50 ( 30 % ) ( consider moderate disability ) ; 3 . Skeletally mature adult age 1870 year time surgery ; 4 . Has complete least six ( 6 ) week conservative therapy ; 5 . Psychosocially , mentally physically able fully comply protocol include adhere schedule visit , treatment plan , complete form , study procedure ; 6 . Personally sign date informed consent document prior studyrelated procedure indicate patient inform pertinent aspect study . 1 . More one vertebral level fuse ; 2 . Posterior instrumentation necessary level ; 3 . Has previous surgery index level ; 4 . Has fuse level adjacent index level ; 5 . Active systemic local infection ; 6 . Known documented history communicable disease , include AIDS HIV ; 7 . Active hepatitis ( receive medical treatment within two year ) ; 8 . Active rheumatoid arthritis , noncontrolled diabetes mellitus , medical condition ( ) would represent significant increase surgical risk interfere normal healing ; 9 . Immunologically suppressed , receive systemic steroid , exclude nasal steroid , dose daily &gt; 1 month within last 12 month ; 10 . Known history Paget 's disease , osteomalacia , metabolic bone disease ; 11 . Osteopenia Osteoporosis : A screening questionnaire osteoporosis , SCORE ( Simple Calculated Osteoporosis Risk Estimation ) , use screen patient require DEXA bone mineral density measurement . If DEXA require , exclusion define DEXA bone density measure T score â‰¤ 1.0 . 12 . Previous know allergy material contain device , polyetheretherketone ( PEEK ) titanium alloy ( TAN ) ; 13 . Morbid obesity define body mass index &gt; 40 kg/m2 weight 100 pound ideal body weight ; 14 . Active malignancy . A patient history invasive malignancy ( except nonmelanoma skin cancer ) , unless treat curative intent clinical sign symptom malignancy 5 year ; 15 . Current recent history ( within last 2 year ) substance abuse ( e.g. , recreational drug , narcotic , alcohol ) ; 16 . Pregnant plan become pregnant study period ; 17 . Involved study another investigational product may affect outcome ; 18 . History psychosocial disorder could prevent accurate completion self report assessment scale ; 19 . Patients incarcerate .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>SCDD</keyword>
</DOC>